MMA Test

Methylmalonic acid (MMA) is a small molecule naturally produced in the body when certain proteins and fats are broken down for energy. Under normal conditions, MMA remains at very low levels because our bodies quickly convert it into a harmless compound called succinyl-CoA, which enters the Krebs cycle, the main energy-producing pathway inside our cells.

This conversion process requires a special helper molecule: vitamin B12 (also called cobalamin). Without enough vitamin B12, MMA starts to accumulate. This makes MMA a very sensitive marker for detecting early vitamin B12 deficiency, even before symptoms like fatigue, nerve damage, or anemia appear.

However, MMA levels are influenced by more than just vitamin B12 status. Kidney health is another important factor. Healthy kidneys help remove MMA from the blood. When kidney function declines, MMA levels can rise even if vitamin B12 levels are normal. That is why it’s critical to consider kidney function when interpreting MMA results.

In addition to vitamin B12 deficiency and kidney disease, elevated MMA has broader health implications. Higher MMA levels have been linked to increased risks of cardiovascular disease, cancer aggressiveness, and all-cause mortality, particularly in older adults. Researchers believe this may be due to MMA’s ability to disrupt mitochondria, the energy-producing structures inside cells. Mitochondrial dysfunction leads to oxidative stress, a state where harmful molecules damage our tissues, accelerating aging and disease processes.

Rarely, MMA can rise to very high levels in inherited metabolic disorders, such as methylmalonic acidemia. In these cases, a genetic defect blocks MMA breakdown, causing severe symptoms in infancy or childhood, including developmental delays, metabolic crises, and organ damage.

Measuring MMA can therefore provide insights beyond traditional vitamin B12 blood tests. For example, a person’s vitamin B12 level might look normal on a basic test but still be functionally low, leading to elevated MMA. This makes MMA a more sensitive marker for detecting subtle or “tissue-level” B12 deficiencies.